Oncocyte Corp Quarterly Return On Equity in % from Q3 2016 to Q2 2024
-
Taxonomy & unit
-
ratio: %
-
Description
-
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
-
Summary
-
Oncocyte Corp quarterly/annual Return On Equity history and growth rate from Q3 2016 to Q2 2024.
- Oncocyte Corp Return On Equity for the quarter ending June 30, 2024 was -157 %, a 25.6% decline year-over-year.
- Oncocyte Corp annual Return On Equity for 2023 was -80.4 %, a 30.7% increase from 2022.
- Oncocyte Corp annual Return On Equity for 2022 was -116 %, a 69.2% decline from 2021.
- Oncocyte Corp annual Return On Equity for 2021 was -68.6 %, a 17.3% increase from 2020.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Growth (%)